Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1692234 Seattle, WA
Back to ALLO Full portfolio

Position in ALLO

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$911,889
+$466,973 QoQ
Shares Held
438,409
+140.4% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 209 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 90% Shared 0% None 10%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. ALLO ranks #129 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in ALLO

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $911,889 438,409
2026-03-31 $444,916 182,344
2025-12-31 $54,855 40,041
2025-09-30 $27,086 21,844
2025-06-30 $219 194
2025-03-31 $3,744 2,565
2024-12-31 $1,250 587
2024-06-30 $186,859 80,197
2022-09-30 $288,013 26,668
2022-03-31 $322,494 35,400
2021-09-30 $196,373 7,641
2021-06-30 $34,112 1,308
2021-03-31 $2,041,362 57,829
2020-12-31 $1,756,022 69,573
2020-09-30 $1,072,358 28,437
2020-06-30 $173,463 4,051
2020-03-31 $230,538 11,859